David R. Khan

650 total citations
9 papers, 491 citations indexed

About

David R. Khan is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, David R. Khan has authored 9 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 7 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in David R. Khan's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Nanoplatforms for cancer theranostics (3 papers). David R. Khan is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Nanoplatforms for cancer theranostics (3 papers). David R. Khan collaborates with scholars based in United States. David R. Khan's co-authors include Edna Cukierman, Gregg B. Fields, Evonne M. Rezler, Janelle L. Lauer‐Fields, Julia Brown, Remedios Castelló-Cros, Matthildi Valianou, Mare Čudić, Raymond S. Tu and Matthew Tirrell and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical Pharmacology and BMC Cancer.

In The Last Decade

David R. Khan

9 papers receiving 472 citations

Peers

David R. Khan

BIOMA

MB

BE

ONCOL

CB

Seulki Lee South Korea

Prajna Mishra India

Alessandro Marengo Italy

Somayeh Shahreza United Kingdom

Stephen Kalscheuer United States

Taryn R. Bagby United States

Beom Suk Lee South Korea

Minglu Zhou China

Ella N. Hoogenboezem United States

Tiantian Tan China

Seulki Lee South Korea

David R. Khan

193 ×0.7

BIOMA

260 ×1.1

MB

185 ×1.1

BE

78 ×0.8

ONCOL

27 ×0.6

CB

Citations per year, relative to David R. Khan David R. Khan (= 1×) peers Seulki Lee

Countries citing papers authored by David R. Khan

Since Specialization

Citations

This map shows the geographic impact of David R. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Khan more than expected).

Fields of papers citing papers by David R. Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Khan. The network helps show where David R. Khan may publish in the future.

Co-authorship network of co-authors of David R. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Khan. A scholar is included among the top collaborators of David R. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Khan. David R. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Khan, David R., et al.. (2015). Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer. Breast Cancer Basic and Clinical Research. 9s2(Suppl 2). BCBCR.S29421–BCBCR.S29421. 36 indexed citations

2.

Brown, Julia & David R. Khan. (2012). The Treatment of Breast Cancer Using Liposome Technology. Journal of Drug Delivery. 2012. 1–6. 42 indexed citations

3.

Khan, David R., et al.. (2011). Recent Patents on Liposomal-Based Chemotherapeutics with a Triggered Release Mechanism. 1(1). 1–6. 1 indexed citations

4.

Cukierman, Edna & David R. Khan. (2010). The benefits and challenges associated with the use of drug delivery systems in cancer therapy. Biochemical Pharmacology. 80(5). 762–770. 126 indexed citations

5.

Khan, David R.. (2010). The use of Nanocarriers for Drug Delivery in Cancer Therapy David R. Khan. Journal of Cancer Science & Therapy. 2(3). 58–62. 49 indexed citations

6.

Castelló-Cros, Remedios, et al.. (2009). Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins. BMC Cancer. 9(1). 94–94. 83 indexed citations

7.

Khan, David R., Evonne M. Rezler, Janelle L. Lauer‐Fields, & Gregg B. Fields. (2007). Effects of Drug Hydrophobicity on Liposomal Stability. Chemical Biology & Drug Design. 71(1). 3–7. 78 indexed citations

8.

Rezler, Evonne M., David R. Khan, Raymond S. Tu, Matthew Tirrell, & Gregg B. Fields. (2007). Peptide-Mediated Targeting of Liposomes to Tumor Cells. Methods in molecular biology. 386. 269–298. 18 indexed citations

9.

Rezler, Evonne M., et al.. (2007). Targeted Drug Delivery Utilizing Protein-Like Molecular Architecture. Journal of the American Chemical Society. 129(16). 4961–4972. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact